POST Online Media Lite Edition



 

Perrigo net sales for calendar year increased 28%

Staff writer |
Perrigo Company announced results for the fourth quarter and calendar year ended December 31, 2015.

Article continues below






Net sales for calendar year 2015 were $5.35 billion, an increase of 28% on a reported basis.

On a constant currency basis, net sales for the year increased 30% over calendar year 2014, attributable primarily to $1.03 billion related to the inclusion of the BCH segment and 14% growth in the Rx segment on a constant currency basis.

Legacy Perrigo new product sales were $365 million for the year. The increase in net sales was partially offset by $197 million in discontinued products and $80 million of unfavorable foreign currency movements.

Net sales in the quarter were $1.42 billion, an increase of 33% on a reported basis.

On a constant currency basis, net sales in the quarter increased 34% over the fourth quarter of 2014, attributable primarily to $326 million related to the inclusion of the BCH segment and 6% growth in the CHC segment on a constant currency basis.

Legacy Perrigo new product sales were $85 million. The increase in net sales was partially offset by $47 million in discontinued products.


What to read next

Perrigo Q1 net sales to $1.33 – $1.35 billion
Perrigo Company Q2 net sales were $1.5 billion
Perrigo increased full-year 2016 adjusted EPS to $10.10